🇺🇸 FDA
Pipeline program

Liposomal Bupivacaine Infiltration

HP-00054364

Approved small_molecule terminated

Quick answer

Liposomal Bupivacaine Infiltration for Postoperative Pain is a Approved program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Pacira BioSciences
Indication
Postoperative Pain
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials